Good morning, Elizabeth Holmes is not the first businessperson for whom ruthless ambition untethered from reality resulted in a fraud conviction. Nor will she be the last. What, then, is the startup community to make of the spectacular rise and fall of the Theranos founder? There's a fascinating post-mortem discussion to be had around the inner turmoil of the entrepreneur who pursues the path of outsize ambition. To succeed, such founders must effectively walk the line between projecting hope and inspiration, and responding to the obstacles inevitably thrown in their way. But how? For perspective, managing editor Lindsay Blakely talked to entrepreneurs and investors in biotech and healthcare, spheres known for long innovation cycles. Good scientists are trained to be skeptical of–and even doubt–their own results. Read on for what founders in every industry could learn from their approach. |
0 Comments:
Post a Comment